核医学診療の革新と加速器科学

抄録

Innovation of nuclear medicine practice is ongoing. It is a theranostics of PET and SPECT imaging-based radioisotope (RI) therapy. In this process, stable supply of RIs is a key issue. Current international supply chain of medical RI is at risk of shortage in spite of increasing needs. Accelerators are expected to produce medical RI and to contribute to sustainable nuclear medicine practice especially for patients with cancers.